W
Wockhardt Ltd
NSE:WOCKPHARMA
Wockhardt Ltd
NSE:WOCKPHARMA
Price:
572.65 INR
5%
Market Closed
Updated:
Jun 10, 2024
Section:
Relative Value
The Relative Value of one WOCKPHARMA stock under the Base Case scenario is 359.49 INR. Compared to the current market price of 572.65 INR, Wockhardt Ltd is Overvalued by 37%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
WOCKPHARMA
Relative Value
Base Case
359.49
INR
Overvaluation 37%
W
Valuation Multiples
Multiples Across Competitors
WOCKPHARMA Competitors Multiples
Wockhardt Ltd Competitors
Wockhardt Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
W
|
Wockhardt Ltd
NSE:WOCKPHARMA
|
82.5B INR | 3 | -16.5 | 61.7 | -162 | |
| JP |
N
|
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
|
776 550.9T JPY | 4 211 733 | -5 347 888.9 | -5 459 134.4 | -5 046 864.6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
807.8B USD | 22.5 | 131.6 | 64.3 | 73.1 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
4.4T DKK | 18.1 | 49.4 | 36.8 | 40.4 | |
| UK |
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | 578.3 | -15 783.5 | 3 846.3 | 17 702.3 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
354B USD | 4.1 | 9.2 | 11.3 | 14.8 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
330.9B USD | 5.4 | 143.5 | 35.7 | 58.3 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
195.3B GBP | 5.2 | 39.2 | 175.3 | 279.6 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
191.8B CHF | 3.3 | 16.7 | 9.4 | 11.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
184.3B CHF | 3.5 | 11.7 | 8.9 | 13 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
162B USD | 2.9 | -524.2 | 12.7 | 20.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
